A Podcast Series from Cerevel’s Chief Scientific Officer, Dr. John Renger, dedicated to understanding the personal side of today’s neuroscience drug hunters.
Episode 15: Mark Bodenrader, Senior Vice President, Finance and Chief Accounting Officer
On this episode of Drug Hunters, Dr. John Renger sits down with Cerevel’s Senior Vice President, Finance and Chief Accounting Officer, Mark Bodenrader. Mark is responsible for all aspects of Finance and Accounting and provides an inside look at his talented team’s ability to partner with the business to ensure seamless support. This way, Cerevel’s various functions can focus on what they do best, like bringing new therapies to patients. Mark also chats about the excitement of Cerevel’s early days, and what he looks forward to most about our future.
3 Jun 2024
Episode 14: Northeastern University Science Team Co-Ops Cohort 3
On this episode of Drug Hunters, Dr. John Renger chats with Cerevel’s 2024 Northeastern Co-Ops to learn what sparked their interest in Cerevel, their predictions for the future in the world of drug discovery, and what they value most about the co-op program.
2 Apr 2024
Episode 13: TMEM175 Compound Team
On the next episode of Drug Hunters, Dr. John Renger catches up with Cerevel’s own TMEM175 Compound team to learn more about the complexities that accompany screening this gene. We hear about both the goals and challenges in this program.
29 Jan 2024
Episode 12: Executive Assistant to the CSO, Kristen Larrabee
On this episode of Drug Hunters, Dr. John Renger interviews his executive assistant, Kristen Larrabee. Kristen recounts her early days as an assistant in various industries, and what led her to join Cerevel. She describes candidly what it’s like to support Dr. John Renger, and his larger organization, with some creative strategies. Enjoy!
5 Jan 2024
Episode 11: Senior Director, Research Operations, Dr. Kim Kerr
On the next episode of Drug Hunters, Dr. John Renger sits down with Cerevel’s Senior Director of Research Operations, Dr. Kim Kerr. Kim takes us through her group’s mission to support the scientists in what they do; science! We get a closer inside look at how her team acts as the operational glue for the CSO organization in providing nonclinical project management support, program management support for early programs and beyond, lab infrastructure, Environmental Health and Safety and Facilities.
5 Jan 2024
Episode 10: Vice President, Drug Metabolism & Pharmacokinetics (DMPK), Dr. Srinivas Chakilam
On this episode of Cerevel Drug Hunters, Dr. John Renger interviews Dr. Srinivas Chakilam, Vice President, Drug Metabolism and Pharmacokinetics (DMPK). We get an inside look into what Srinivas and his team do at Cerevel to uncover and understand molecule properties from the research stage all the way to filing NDAs (New Drug Applications). They help to unravel how the drug is metabolized and what it does to the body to glean efficacy information.
3 Nov 2023
Episode 9: Cerevel Veteran Employee Resource Group
On the next episode of Drug Hunters, Dr. John Renger interviews two members from CereVets, Cerevel’s newly launched Veteran Employee Resource Group. The episode features Jack Homsher VP, Human Resources (former Senior Chief, and SEAL, US Navy), and Francisco Guzman, Principal Scientist, Process Development (former First-class Petty Officer, US Navy). Listen to learn about this group’s important mission within Cerevel. You can also hear first-hand what it’s been like for Jack and Francisco to transition from the US Navy into the Cambridge, MA, biopharmaceuticals world where they are now using their experiences and skillsets to combat neuroscience diseases!
26 Oct 2023
Episode 8: SVP of CMC Technical Operations, Dr. Andy Clausen
On this episode of Cerevel Drug Hunters, Dr. John Renger sits down one-on-one with Cerevel’s own SVP of CMC Technical Operations, Dr. Andy Clausen. We get an inside look into the Technical Operations and CMC teams at Cerevel, and learn about Andy’s exciting career journey. You won’t want to miss this!
1 Aug 2023
Episode 7: Vice President of Biology, Dr. Phil Iredale
On this episode of Cerevel Drug Hunters, Dr. John Renger sits down with our VP of Biology, Dr. Phil Iredale. Phil dives into his role of managing the Biology department, all targets, how we arrive at some of the new programs we decide to run, and the mechanisms behind the drugs we are developing. We also get a glimpse into the journey that led Phil to Cerevel. Enjoy!
2 May 2023
Episode 6: Vice President of Genetics & Target Identification, Dr. Dave Stone
On the next episode of Drug Hunters, Dr. John Renger interviews Cerevel’s Vice President of Genetics & Target Identification, Dr. Dave Stone. Dave chats about the genes we target, and how his team strategically thinks about the programs we want to build out in our early pipeline in order to deliver new therapeutics to our patients.
2 May 2023
Episode 5: Northeastern University Science Team Co-Ops Cohort 2
On this episode of Drug Hunters, Dr. John Renger chats with Cerevel’s 2023 Northeastern Co-Ops to gain insight into what drew these students to Cerevel initially, their diverse career aspirations, and what they value most from the co-op program.
2 May 2023
Episode 4: Senior Director and Head of Search & Evaluation, Dr. Yong Mi Choi
On the next episode of Drug Hunters, Dr. John Renger interviews Cerevel’s Senior Director and Head of Search and Evaluation, Dr. Yong Mi Choi. Yong Mi describes what goes into her role of identifying transformative partnership opportunities and finding new technologies that can accelerate the progress of our existing early discovery programs.
1 May 2023
Episode 3: Northeastern University Science Team Co-Ops
On this episode of Drug Hunters, Dr. John Renger chats with Cerevel’s 2022 Northeastern Co-Ops to gain insight into what drew these students to Cerevel initially, their diverse career aspirations, and what they valued most from the co-op program.
1 May 2023
Episode 2: Vice President of Clinical Pharmacology & Pharmacometrics, Dr. Sridhar Duvvuri
Our highly anticipated second podcast features Dr. John Renger interviewing Cerevel’s Vice President of Clinical Pharmacology & Pharmacometrics, Dr. Sridhar Duvvuri. Sridhar describes what motivates and drives him and his team in their work at Cerevel to treat unmet patient needs from the pre-clinical to bedside phase of treatment.
1 May 2023
Episode 1: Senior Vice President, Safety Assessment & Research Ops, Dr. Rick Briscoe
The first podcast features Dr. Rick Briscoe, Senior Vice President, Safety Assessment and Research Operations, discussing his journey, aspirations, and personal motivation for developing new solutions for people living with neuroscience diseases.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.5 / 5
6 ratings
Contact Cerevel Drug Hunters
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Cerevel Drug Hunters?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
